An artificial intelligence solution that can identify precancerous changes in a woman’s cervix, comes on the heels of a Mayo Clinic Study that shows the percentage of women who are screened for cervical cancer could be far lower than national data suggests.
Infervision’s deep-learning system alerts radiologists to the possible presence of four different diseases, which could lead to faster and more comprehensive diagnoses.
With the explosion of artificial intelligence and its overall acceptance in healthcare along with strong data supporting the WATS3D test, could 2019 be a breakthrough year for CDx Diagnostics.
Osaka University researchers have developed an AI-based system that has the potential to differentiate between different types of cancer cells. The research could have major implications in the field of oncology.
CLARITY enables the formation of a hydrogel matrix by crosslinking biological molecules to a 3D network of hydrophilic polymers followed by lipid removal to generate a transparent, structurally intact tissue. The tissue retains its original structural features, can be labeled with macromolecules, and subsequently imaged without destruction of tissue morphology.
The Los Altos, CA-based company has raised $20 million in a series C round to help with market adoption of its Triton solution.
The Nashua, NH-based company plans to showcase the technology at The European Society of Breast Imaging annual meeting being held this weekend and at RSNA.
An expert lays out how the medtech industry can adapt to Virtual and Augmented Reality changing the healthcare landscape.
The company has developed an AI solution to detect diabetic retinopathy and is looking at the possibility of an IPO in the future.
Two separate studies show how researchers are using machine learning to train computers to spot and classify cells just by analyzing medical images.
New data unveiled at the European Respiratory Society International Congress shows that the Archimedes virtual bronchoscopy navigation system significantly improves the diagnostic yield of lung cancer nodules located outside a patient's main airways.
The founders of Fuzionaire Dx talked to MD+DI about how a chemistry breakthrough led to the formation of the company and attracted the help of Michael Phelps, the original inventor of the PET scanner.
4Dx has developed an algorithm-based software that converts X-ray images into more detailed airflow studies.
Doctors from AmCad BioMed Corp have developed a new screening and imaging tool specifically designed to improve the early detection of thyroid cancer with advanced ultrasound technology.